Results 81 to 90 of about 10,494 (219)

Pityriasis Lichenoides: Comparison of Two Pediatric Patients and Its Relationships With Vaccines and Infections

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Pityriasis lichenoides (PL) is a benign, self‐limiting inflammatory condition, characterized by the appearance of papular, scaly, or necrotic lesions. Despite the rare incidence, clinicians should suspect its diagnosis in the presence of specific skin lesions and epidemiological contexts, as suggested by its association with infections and/or ...
Gregorio Serra   +7 more
wiley   +1 more source

Langerhans Cell Histiocytosis in a Newborn

open access: yesJournal of the Chinese Medical Association, 2009
A full-term female baby was admitted to our hospital at the postnatal age of 37 days with generalized vesiculopapular, crateriform skin lesions. Physical examination revealed a well-nourished baby without fever, hepatosplenomegaly or lymphadenopathy. Laboratory examination was normal except for thrombocytosis (platelet count, 970 x 10(3)/microL).
Yang, Tzu-Ying   +3 more
openaire   +2 more sources

Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study

open access: yesOrphanet Journal of Rare Diseases, 2017
BackgroundVinblastine is the standard treatment for children with Langerhans cell histiocytosis (LCH). Whether this treatment could be extended to adults with LCH is questionable.
A. Tazi   +14 more
semanticscholar   +1 more source

Skull Base Langerhans Cell Histiocytosis with Diabetes Insipidus and Panhypopituitarism- A Rare Clinical Entity

open access: yesBengal Journal of Otolaryngology and Head Neck Surgery, 2017
Introduction A case of Langerhans cell histiocytosis (LGH) involving extensive area of base of skull resulting in panhypopituitarism and diabetes insipidus (DI) is reported.
Anirban Ghosh   +2 more
doaj   +3 more sources

Doença de células de langerhans e mama.

open access: yesActa Médica Portuguesa, 2011
Langerhans cell histiocytosis (LCH) is a rare systemic disorder, with a diversified presentation and natural history. It can compromise any organ. We report a case of a 32-year-old woman who came to our clinic with an asymptomatic palpable breast mass ...
Cátia Rodrigues   +4 more
doaj   +1 more source

Cutaneous Crystal‐Storing Histiocytosis With Marginal Zone Lymphoma. A Case Report With A Striking Clinical Presentation

open access: yesJournal of Cutaneous Pathology, Volume 53, Issue 7, Page 576-580, July 2026.
ABSTRACT Cutaneous crystal‐storing histiocytosis (CSH) is an extremely rare histopathologic finding of histiocytes accumulating crystals of immunoglobulin or paraproteins, often associated with lymphoplasmacytic malignancies. It commonly presents in a wide age range of both female and male adults with a history of a lymphoproliferative disorder ...
Ashton Arlen   +3 more
wiley   +1 more source

How I manage pulmonary Langerhans cell histiocytosis

open access: yesEuropean Respiratory Review, 2017
Pulmonary Langerhans cell histiocytosis (PLCH) is a rare sporadic cystic lung disease of unknown aetiology that is characterised by the infiltration and destruction of the wall of distal bronchioles by CD1a+ Langerhans-like cells.
G. Lorillon, A. Tazi
semanticscholar   +1 more source

Periodontitis and Periodontal Conditions in Systemically Healthy Children and Adolescents

open access: yesJournal of Clinical Periodontology, Volume 53, Issue 7, Page 1100-1198, July 2026.
ABSTRACT Objective To answer the PICoS question ‘in systemically healthy children and adolescents (Population), what are the main features of periodontitis, necrotising periodontal diseases (NPD) and other periodontal conditions (periodontal abscesses, endo‐periodontal lesions, traumatic occlusal forces, prosthesis‐ and tooth‐related factors ...
Inbar Eshkol‐Yogev   +5 more
wiley   +1 more source

New somatic BRAF splicing mutation in Langerhans cell histiocytosis

open access: yesMolecular Cancer, 2017
Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia with constitutive activation of the MAPKinase RAS-RAF-MEK-ERK cell signaling pathway. We analyzed 9 LCH cases without BRAFV600 and MAP2K1 mutations by whole exome sequencing.
S. Héritier   +10 more
semanticscholar   +1 more source

Novel BRAF fusion in Erdheim–Chester disease with pulmonary manifestations: Importance of RNA‐based testing and response to MEK inhibition

open access: yes
Histopathology, EarlyView.
Igor Odintsov   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy